Toyota plans to use same batteries as Tesla for China plug-in hybrids

·    The automaker is using batteries designed by Panasonic for Levin and Corolla hybrid sedans for the Chinese market.  ·    The move will help Toyota secure high-quality batteries as well a....

Momotaro doses first patient with MTG201 in its Phase 2 clinical trial

The Phase 2 study will register approx. twelve patients diagnosed with malignant mesothelioma that have failed systemic platin-based front-line chemotherapy.   The key objective of the trial is to evaluate efficacy of MTG201- Nivol....

Sanofi pays $260Mn to terminate its partnership with Lexicon

The announcement resulted in a sudden surge of Lexicon’s shares, which went up by 37.8% to $2.37 in after-hours trading. France-based multinational pharma conglomerate Sanofi SA, is reportedly liable to pay a sum of $260 million to L....

Accenture acquires Pragsis Bidoop to strengthen technology expertise

The company plans to expand its technology expertise to help clients scale their AI capabilities and accelerate data-driven model.   Pragsis Bidoop will play a vital role in strengthening Accenture’s Applied Intelligence unit....

Patriot One buys XTRACT Tech to augment PATSCAN Platform capabilities

Patriot One is thrilled to integrate a highly talented team join its ranks since they share the company’s vision for building a world that is safe from mass violence. XTRACT team will bring with it leading-edge expertise in machine....

Servier, Ipsen release initial Phase II/III clinical data of ONIVYDE®

The results from the Phase II/III trials, which involved efficacy data and preliminary safety, was presented at the IASLC 2019 World Conference on Lung Cancer, held in Barcelona, Spain. Ipsen, a French pharmaceutical company, and Serv....

Ceridian inks an agreement to acquire WFM solution provider RITEQ

The acquisition would advance Ceridian’s momentum in New Zealand and the Australian markets. Ceridian HCM, Inc., a leading human capital management (HCM) technology company, has recently announced that it has signed a definitive shar....

Rocket Pharmaceutical unveils plans for Phase 2 trials of RP-L102

The company is set to initiate a Phase 2 clinical trial in the U.S. after a successful Phase 1 trial in Spain. Rocket Pharmaceuticals, Inc., a U.S.-based biotechnology company, has recently announced the U.S. Phase 2 clinical advancement t....

Lupin and Boehringer Ingelheim join hands to develop anti-cancer drug

The 2 major companies have inked a deal valued at USD 700 million for the development of the cancer drug.   Lupin to receive royalty on the sales of the drug developed while retaining the commercial rights to the program in India. ....

Rambus to acquire Secure Protocols & Silicon IP business of Verimatrix

Verimatrix and Rambus plan to enter an asset purchase agreement after placing certain pre-conditions.   The deal would allow the company to expand its global reach and deliver security solutions worldwide. Rambus Inc., a prime si....

Our Contributors

$row3->name
Mateen Dalal
$row3->name
Akshay Kedari
« First7879808182Last »